Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study
We investigated prevalence and predictive factors for ESBL-E carriage in a population of mostly travellers prior to their travel (n = 2216). In addition, we examined ESBL genotype before travel and compared these to returning travellers. A questionnaire and faecal sample were collected before travel...
Gespeichert in:
| Veröffentlicht in: | Travel medicine and infectious disease 2020-01, Vol.33, p.101547-101547, Article 101547 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 101547 |
|---|---|
| container_issue | |
| container_start_page | 101547 |
| container_title | Travel medicine and infectious disease |
| container_volume | 33 |
| creator | Arcilla, Maris S. Van Hattem, Jarne M. Bootsma, Martin C.J. van Genderen, Perry J.J. Goorhuis, Abraham Grobusch, Martin P. Klaassen, Corné H.W. Oude Lashof, Astrid M. Schultsz, Constance Stobberingh, Ellen E. de Jong, Menno D. Penders, John Verbrugh, Henri A. Melles, Damian C. |
| description | We investigated prevalence and predictive factors for ESBL-E carriage in a population of mostly travellers prior to their travel (n = 2216). In addition, we examined ESBL genotype before travel and compared these to returning travellers.
A questionnaire and faecal sample were collected before travel, and a second faecal sample was collected immediately after travel. Faecal samples were analysed for ESBL-E, with genotypic characterization by PCR and sequencing. Risk factors for ESBL-E carriage prior to travel were identified by logistic regression analyses.
Before travel, 136 participants (6.1%) were colonized with ESBL-E. Antibiotic use in the past three months (ORadjusted 2.57; 95% CI 1.59–4.16) and travel outside of Europe in the past year (1.92, 1.28–2.87) were risk factors for ESBL-E colonisation prior to travel. Travel outside of Europe carried the largest attributable risk (39.8%). Prior to travel 31.3% (40/128) of participants carried blaCTX-M 15 and 21.9% (28/128) blaCTX-M 14/18. In returning travellers 633 acquired ESBL-E of who 53.4% (338/633) acquired blaCTX-M 15 and 17.7% (112/633) blaCTX-M 14/18.
In our population of Dutch travellers we found a pre-travel ESBL-E prevalence of 6.1%. Prior to travel, previous antibiotic use and travel outside of Europe were the strongest independent predictors for ESBL-E carriage, with travel outside of Europe carrying the largest attributable risk. Our molecular results suggest ESBL genes found in our study population prior to travel were in large part travel related. |
| doi_str_mv | 10.1016/j.tmaid.2019.101547 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2329734213</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1477893919302662</els_id><sourcerecordid>2417015115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-95bbe13e2b03dad3b14b945963c4b931c66bf794f382c412b36d6e629d31428f3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EoqXwBEjIEptuMsS-jpMgsShlgEojFQlYW_65KR4y8WA7I_UV-tQ4ncKCBStfWd-5P-cQ8pLVK1Yz-Wa7yjvt3YrXrF9-GtE-Iqesa6GqheCPSy3atup66E_Is5S2dQ1NJ-ApOQHWSc6FPCV3XyIe9IiTRaonR6NPP-mgbQ4x0SFEanWMXt8gDQNdf32_qfYxuNn66Yaup4wxmAJjQSxqpH6imu7Dfh519mFaRB_mbH_QHPUBxxFjeksvqI0hpSqhXSA90pRnd_ucPBn0mPDFw3tGvn9cf7v8XG2uP11dXmwqK4Dnqm-MQQbITQ1OOzBMmF40vQRbCmBWSjO0vRig41YwbkA6iZL3Dpjg3QBn5PzYt1zya8aU1c4nW5bTE4Y5KQ68b0FwBgV9_Q-6DXMsGxdKsLZ4zlhTKDhS92dFHNQ--p2Ot4rVaolKbdV9VGqJSh2jKqpXD71ns0P3V_MnmwK8OwJYzDh4jCpZvwTlfCzOKRf8fwf8Bkp7pjw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417015115</pqid></control><display><type>article</type><title>Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Arcilla, Maris S. ; Van Hattem, Jarne M. ; Bootsma, Martin C.J. ; van Genderen, Perry J.J. ; Goorhuis, Abraham ; Grobusch, Martin P. ; Klaassen, Corné H.W. ; Oude Lashof, Astrid M. ; Schultsz, Constance ; Stobberingh, Ellen E. ; de Jong, Menno D. ; Penders, John ; Verbrugh, Henri A. ; Melles, Damian C.</creator><creatorcontrib>Arcilla, Maris S. ; Van Hattem, Jarne M. ; Bootsma, Martin C.J. ; van Genderen, Perry J.J. ; Goorhuis, Abraham ; Grobusch, Martin P. ; Klaassen, Corné H.W. ; Oude Lashof, Astrid M. ; Schultsz, Constance ; Stobberingh, Ellen E. ; de Jong, Menno D. ; Penders, John ; Verbrugh, Henri A. ; Melles, Damian C.</creatorcontrib><description>We investigated prevalence and predictive factors for ESBL-E carriage in a population of mostly travellers prior to their travel (n = 2216). In addition, we examined ESBL genotype before travel and compared these to returning travellers.
A questionnaire and faecal sample were collected before travel, and a second faecal sample was collected immediately after travel. Faecal samples were analysed for ESBL-E, with genotypic characterization by PCR and sequencing. Risk factors for ESBL-E carriage prior to travel were identified by logistic regression analyses.
Before travel, 136 participants (6.1%) were colonized with ESBL-E. Antibiotic use in the past three months (ORadjusted 2.57; 95% CI 1.59–4.16) and travel outside of Europe in the past year (1.92, 1.28–2.87) were risk factors for ESBL-E colonisation prior to travel. Travel outside of Europe carried the largest attributable risk (39.8%). Prior to travel 31.3% (40/128) of participants carried blaCTX-M 15 and 21.9% (28/128) blaCTX-M 14/18. In returning travellers 633 acquired ESBL-E of who 53.4% (338/633) acquired blaCTX-M 15 and 17.7% (112/633) blaCTX-M 14/18.
In our population of Dutch travellers we found a pre-travel ESBL-E prevalence of 6.1%. Prior to travel, previous antibiotic use and travel outside of Europe were the strongest independent predictors for ESBL-E carriage, with travel outside of Europe carrying the largest attributable risk. Our molecular results suggest ESBL genes found in our study population prior to travel were in large part travel related.</description><identifier>ISSN: 1477-8939</identifier><identifier>EISSN: 1873-0442</identifier><identifier>DOI: 10.1016/j.tmaid.2019.101547</identifier><identifier>PMID: 31862246</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Antibiotics ; Antimicrobial agents ; Carriage ; Community ; Cross-sectional studies ; DNA ; E coli ; ESBL ; Genes ; Genotypes ; Health care ; Infectious diseases ; Nucleotide sequence ; PCR ; Population ; Risk factors ; Travel ; Travel medicine</subject><ispartof>Travel medicine and infectious disease, 2020-01, Vol.33, p.101547-101547, Article 101547</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><rights>2019. The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-95bbe13e2b03dad3b14b945963c4b931c66bf794f382c412b36d6e629d31428f3</citedby><cites>FETCH-LOGICAL-c432t-95bbe13e2b03dad3b14b945963c4b931c66bf794f382c412b36d6e629d31428f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1477893919302662$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31862246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arcilla, Maris S.</creatorcontrib><creatorcontrib>Van Hattem, Jarne M.</creatorcontrib><creatorcontrib>Bootsma, Martin C.J.</creatorcontrib><creatorcontrib>van Genderen, Perry J.J.</creatorcontrib><creatorcontrib>Goorhuis, Abraham</creatorcontrib><creatorcontrib>Grobusch, Martin P.</creatorcontrib><creatorcontrib>Klaassen, Corné H.W.</creatorcontrib><creatorcontrib>Oude Lashof, Astrid M.</creatorcontrib><creatorcontrib>Schultsz, Constance</creatorcontrib><creatorcontrib>Stobberingh, Ellen E.</creatorcontrib><creatorcontrib>de Jong, Menno D.</creatorcontrib><creatorcontrib>Penders, John</creatorcontrib><creatorcontrib>Verbrugh, Henri A.</creatorcontrib><creatorcontrib>Melles, Damian C.</creatorcontrib><title>Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study</title><title>Travel medicine and infectious disease</title><addtitle>Travel Med Infect Dis</addtitle><description>We investigated prevalence and predictive factors for ESBL-E carriage in a population of mostly travellers prior to their travel (n = 2216). In addition, we examined ESBL genotype before travel and compared these to returning travellers.
A questionnaire and faecal sample were collected before travel, and a second faecal sample was collected immediately after travel. Faecal samples were analysed for ESBL-E, with genotypic characterization by PCR and sequencing. Risk factors for ESBL-E carriage prior to travel were identified by logistic regression analyses.
Before travel, 136 participants (6.1%) were colonized with ESBL-E. Antibiotic use in the past three months (ORadjusted 2.57; 95% CI 1.59–4.16) and travel outside of Europe in the past year (1.92, 1.28–2.87) were risk factors for ESBL-E colonisation prior to travel. Travel outside of Europe carried the largest attributable risk (39.8%). Prior to travel 31.3% (40/128) of participants carried blaCTX-M 15 and 21.9% (28/128) blaCTX-M 14/18. In returning travellers 633 acquired ESBL-E of who 53.4% (338/633) acquired blaCTX-M 15 and 17.7% (112/633) blaCTX-M 14/18.
In our population of Dutch travellers we found a pre-travel ESBL-E prevalence of 6.1%. Prior to travel, previous antibiotic use and travel outside of Europe were the strongest independent predictors for ESBL-E carriage, with travel outside of Europe carrying the largest attributable risk. Our molecular results suggest ESBL genes found in our study population prior to travel were in large part travel related.</description><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Carriage</subject><subject>Community</subject><subject>Cross-sectional studies</subject><subject>DNA</subject><subject>E coli</subject><subject>ESBL</subject><subject>Genes</subject><subject>Genotypes</subject><subject>Health care</subject><subject>Infectious diseases</subject><subject>Nucleotide sequence</subject><subject>PCR</subject><subject>Population</subject><subject>Risk factors</subject><subject>Travel</subject><subject>Travel medicine</subject><issn>1477-8939</issn><issn>1873-0442</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kc1u1DAUhS0EoqXwBEjIEptuMsS-jpMgsShlgEojFQlYW_65KR4y8WA7I_UV-tQ4ncKCBStfWd-5P-cQ8pLVK1Yz-Wa7yjvt3YrXrF9-GtE-Iqesa6GqheCPSy3atup66E_Is5S2dQ1NJ-ApOQHWSc6FPCV3XyIe9IiTRaonR6NPP-mgbQ4x0SFEanWMXt8gDQNdf32_qfYxuNn66Yaup4wxmAJjQSxqpH6imu7Dfh519mFaRB_mbH_QHPUBxxFjeksvqI0hpSqhXSA90pRnd_ucPBn0mPDFw3tGvn9cf7v8XG2uP11dXmwqK4Dnqm-MQQbITQ1OOzBMmF40vQRbCmBWSjO0vRig41YwbkA6iZL3Dpjg3QBn5PzYt1zya8aU1c4nW5bTE4Y5KQ68b0FwBgV9_Q-6DXMsGxdKsLZ4zlhTKDhS92dFHNQ--p2Ot4rVaolKbdV9VGqJSh2jKqpXD71ns0P3V_MnmwK8OwJYzDh4jCpZvwTlfCzOKRf8fwf8Bkp7pjw</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Arcilla, Maris S.</creator><creator>Van Hattem, Jarne M.</creator><creator>Bootsma, Martin C.J.</creator><creator>van Genderen, Perry J.J.</creator><creator>Goorhuis, Abraham</creator><creator>Grobusch, Martin P.</creator><creator>Klaassen, Corné H.W.</creator><creator>Oude Lashof, Astrid M.</creator><creator>Schultsz, Constance</creator><creator>Stobberingh, Ellen E.</creator><creator>de Jong, Menno D.</creator><creator>Penders, John</creator><creator>Verbrugh, Henri A.</creator><creator>Melles, Damian C.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>KB0</scope><scope>L.G</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202001</creationdate><title>Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study</title><author>Arcilla, Maris S. ; Van Hattem, Jarne M. ; Bootsma, Martin C.J. ; van Genderen, Perry J.J. ; Goorhuis, Abraham ; Grobusch, Martin P. ; Klaassen, Corné H.W. ; Oude Lashof, Astrid M. ; Schultsz, Constance ; Stobberingh, Ellen E. ; de Jong, Menno D. ; Penders, John ; Verbrugh, Henri A. ; Melles, Damian C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-95bbe13e2b03dad3b14b945963c4b931c66bf794f382c412b36d6e629d31428f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Carriage</topic><topic>Community</topic><topic>Cross-sectional studies</topic><topic>DNA</topic><topic>E coli</topic><topic>ESBL</topic><topic>Genes</topic><topic>Genotypes</topic><topic>Health care</topic><topic>Infectious diseases</topic><topic>Nucleotide sequence</topic><topic>PCR</topic><topic>Population</topic><topic>Risk factors</topic><topic>Travel</topic><topic>Travel medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arcilla, Maris S.</creatorcontrib><creatorcontrib>Van Hattem, Jarne M.</creatorcontrib><creatorcontrib>Bootsma, Martin C.J.</creatorcontrib><creatorcontrib>van Genderen, Perry J.J.</creatorcontrib><creatorcontrib>Goorhuis, Abraham</creatorcontrib><creatorcontrib>Grobusch, Martin P.</creatorcontrib><creatorcontrib>Klaassen, Corné H.W.</creatorcontrib><creatorcontrib>Oude Lashof, Astrid M.</creatorcontrib><creatorcontrib>Schultsz, Constance</creatorcontrib><creatorcontrib>Stobberingh, Ellen E.</creatorcontrib><creatorcontrib>de Jong, Menno D.</creatorcontrib><creatorcontrib>Penders, John</creatorcontrib><creatorcontrib>Verbrugh, Henri A.</creatorcontrib><creatorcontrib>Melles, Damian C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Travel medicine and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arcilla, Maris S.</au><au>Van Hattem, Jarne M.</au><au>Bootsma, Martin C.J.</au><au>van Genderen, Perry J.J.</au><au>Goorhuis, Abraham</au><au>Grobusch, Martin P.</au><au>Klaassen, Corné H.W.</au><au>Oude Lashof, Astrid M.</au><au>Schultsz, Constance</au><au>Stobberingh, Ellen E.</au><au>de Jong, Menno D.</au><au>Penders, John</au><au>Verbrugh, Henri A.</au><au>Melles, Damian C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study</atitle><jtitle>Travel medicine and infectious disease</jtitle><addtitle>Travel Med Infect Dis</addtitle><date>2020-01</date><risdate>2020</risdate><volume>33</volume><spage>101547</spage><epage>101547</epage><pages>101547-101547</pages><artnum>101547</artnum><issn>1477-8939</issn><eissn>1873-0442</eissn><abstract>We investigated prevalence and predictive factors for ESBL-E carriage in a population of mostly travellers prior to their travel (n = 2216). In addition, we examined ESBL genotype before travel and compared these to returning travellers.
A questionnaire and faecal sample were collected before travel, and a second faecal sample was collected immediately after travel. Faecal samples were analysed for ESBL-E, with genotypic characterization by PCR and sequencing. Risk factors for ESBL-E carriage prior to travel were identified by logistic regression analyses.
Before travel, 136 participants (6.1%) were colonized with ESBL-E. Antibiotic use in the past three months (ORadjusted 2.57; 95% CI 1.59–4.16) and travel outside of Europe in the past year (1.92, 1.28–2.87) were risk factors for ESBL-E colonisation prior to travel. Travel outside of Europe carried the largest attributable risk (39.8%). Prior to travel 31.3% (40/128) of participants carried blaCTX-M 15 and 21.9% (28/128) blaCTX-M 14/18. In returning travellers 633 acquired ESBL-E of who 53.4% (338/633) acquired blaCTX-M 15 and 17.7% (112/633) blaCTX-M 14/18.
In our population of Dutch travellers we found a pre-travel ESBL-E prevalence of 6.1%. Prior to travel, previous antibiotic use and travel outside of Europe were the strongest independent predictors for ESBL-E carriage, with travel outside of Europe carrying the largest attributable risk. Our molecular results suggest ESBL genes found in our study population prior to travel were in large part travel related.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>31862246</pmid><doi>10.1016/j.tmaid.2019.101547</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1477-8939 |
| ispartof | Travel medicine and infectious disease, 2020-01, Vol.33, p.101547-101547, Article 101547 |
| issn | 1477-8939 1873-0442 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2329734213 |
| source | ScienceDirect Journals (5 years ago - present) |
| subjects | Antibiotics Antimicrobial agents Carriage Community Cross-sectional studies DNA E coli ESBL Genes Genotypes Health care Infectious diseases Nucleotide sequence PCR Population Risk factors Travel Travel medicine |
| title | Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T17%3A17%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20risk%20factors%20for%20carriage%20of%20ESBL-producing%20Enterobacteriaceae%20in%20a%20population%20of%20Dutch%20travellers:%20A%20cross-sectional%20study&rft.jtitle=Travel%20medicine%20and%20infectious%20disease&rft.au=Arcilla,%20Maris%20S.&rft.date=2020-01&rft.volume=33&rft.spage=101547&rft.epage=101547&rft.pages=101547-101547&rft.artnum=101547&rft.issn=1477-8939&rft.eissn=1873-0442&rft_id=info:doi/10.1016/j.tmaid.2019.101547&rft_dat=%3Cproquest_cross%3E2417015115%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2417015115&rft_id=info:pmid/31862246&rft_els_id=S1477893919302662&rfr_iscdi=true |